Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
Clinical trial NCT02376985 · COMPLETED
Trial details
- NCT number
- NCT02376985
- Sponsor
- Comprehensive Support Project for Oncology Research
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-26
- Primary completion
- 2018-03-31
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.